FDA Adverse Event Death Summary report: N

PIPELINE EMBOLIZATION DEVICE

MDR report key: 3940924 · Received July 17, 2014

Report

Report Number
2029214-2014-00409
Event Type
Death
Date Received
July 17, 2014
Report Date
June 17, 2014
Manufacturer
EV3 NEUROVASCULAR
Product Code
OUT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE INVOLVED IN THE EVENT WILL NOT BE RETURNED FOR EVALUATION AS IT WAS IMPLANTED IN THE PATIENT. (B)(4).

Description of Event or Problem · 1

INFORMATION RECEIVED FROM THE ARTICLE: MONTEITH SJ, M.D., TSIMPAS A, M.D., M.SC., DUMONT AS, MD., ET AL. ENDOVASCULAR TREATMENT OF FUSIFORM CEREBRAL ANEURYSMS WITH THE PIPELINE EMBOLIZATION DEVICE. J NEUROSURG 120. 2014:945-954. A TOTAL OF 146 PATIENT WERE TREATED WITH PIPELINE EMBOLIZATION DEVICE (PED). 24 OF THE 144 WERE IDENTIFIED AS HAVING FUSIFORM ANEURYSMS (9 MEN AND 15 WOMEN) WITH A MEAN AGE OF 59 YEARS. ALL THE PATIENTS WERE GIVEN ANTI-PLATELET THERAPY. 23 OF THE 24 HAD NO PROCEDURAL COMPLICATIONS. ONE HAD A GROIN PSEUDOANEURYSM THAT WAS MANAGED CONSERVATIVELY. 4 OF THE 24 HAD MAJOR COMPLICATIONS RELATED TO THE ANEURYSM TREATMENT AND THERE WAS ONE DEATH. CASE (B)(4): TREATMENT OF A LARGE ANEURYSM MEASURING 22MM X 23MM X 20MM LOCATED IN THE BASILAR TRUNK. THE PATIENT PRESENTED WITH ATAXIA AND CRANIAL NERVE PALSY VI UNDERWENT PIPELINE (5MM X 30MM) EMBOLIZATION TREATMENT INVOLVING ONE PIPELINE WITHOUT ISSUES. THE PATIENT HAD A VP SHUNT PLACED IN PREPARATION FOR THE PREDICTED SWELLING AND AQUEDUCTAL CLOSURE RESULTING FROM THE ANEURYSM THROMBOSIS. THE PATIENT DID WELL. 7 MONTHS POST PROCEDURE, THE PATIENT SUFFERED A SUBARACHNOID HEMORRHAGE AND CARE WAS WITHDRAWN BY THE FAMILY AND HE SUBSEQUENTLY EXPIRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
420150 PIPELINE EMBOLIZATION DEVICE FLOW DIVERSION OUT EV3 NEUROVASCULAR FA-71500-30 NOT REPORTED

Patients

Seq Age Sex Outcome Treatment
1 77 YR Death